Literature DB >> 4997584

In vitro studies of complement function in sera of C4-deficient guinea pigs.

M M Frank, J May, T Gaither, L Ellman.   

Abstract

In vitro studies were performed utilizing sera from a strain of guinea pigs with a total absence of hemolytically active C4. Previous studies in these animals have demonstrated normal complement-dependent inflammatory reactions, suggesting that they are able to bypass their deficiency of C4. In vitro studies with C4-deficient serum also indicate normal activation of late-acting C components. Thus, endotoxin was capable of fixing normal amounts of the late components of complement (C3-9) in these sera, but did not fix C1 and C2. Antigen-antibody complexes fixed both early and late components of complement, although components beyond C4 were fixed less efficiently than in normal sera. Therefore, both in vivo and in vitro evidence indicates that the C4-deficient guinea pigs possess an alternate pathway for activation of late-acting complement components. Antigenic analysis of C4-deficient serum utilizing both guinea pig anti-C4 antibody and rabbit anti-C4 antibody suggests an absolute deficiency of C4-like molecules. Sera from animals with C4-deficiency were found to have one-half the normal level of C2. Sera from five of eight animals tested had 10-20% normal C1 activity. C3-9 assayed as a complex was normal.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4997584      PMCID: PMC2139026          DOI: 10.1084/jem.134.1.176

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

2.  The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.

Authors:  A L Sandberg; A G Osler; H S Shin; B Oliveira
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

3.  The effect of temperature on the reactivity of guinea-pig complement with gamma G and gamma M haemolytic antibodies.

Authors:  M M Frank; T Gaither
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

4.  [Some characteristics of the 6th component of complement].

Authors:  C E Biro; M L Ortega
Journal:  Arch Inst Cardiol Mex       Date:  1966 Mar-Apr

5.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

6.  Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor.

Authors:  R Snyderman; J Phillips; S E Mergenhagen
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

7.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

8.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

9.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

10.  Properties of guinea pig 7S antibodies. III. Identification of antibodies involved in complement fixation and hemolysis.

Authors:  K J BLOCH; F M KOURILSKY; Z OVARY; B BENACERRAF
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  34 in total

1.  Interactions between Mycoplasma pneumoniae and guinea pig complement.

Authors:  W Bredt; D Bitter-Suermann
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants.

Authors:  S Ferrone; A Ting; M A Pellegrino; P I Terasaki; R A Reisfeld
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

3.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

4.  Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum.

Authors:  I Dörner; H Brunner; H G Schiefer; M Loos; H J Wellensiek
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

5.  Effect of immunosuppression on Rickettsia rickettsii infection in guinea pigs.

Authors:  D H Walker; F W Henderson
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

Review 6.  Animal models of inherited complement deficiency.

Authors:  S Linton
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

7.  In vitro synthesis of a regulator of mammalian gene expression.

Authors:  H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

8.  Cytokine gene expression in skin of susceptible guinea-pig infected with Treponema pallidum.

Authors:  V Wicher; A M Scarozza; A I Ramsingh; K Wicher
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

9.  Immunochemical characterization of murine H-2 controlled Ss (serum substance) protein through identification of its human homologue as the fourth component of complement.

Authors:  T Meo; T Krasteff; D C Shreffler
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

10.  Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.

Authors:  M A Kane; J E May; M M Frank
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.